C. Mcculley

发表

Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study

I. Graham, K. Bushby, F. Muntoni, 2009, The Lancet Neurology.

Hsp90 inhibition protects against inherited retinal degeneration

P. Garriga, C. Gias, P. Coffey, 2013, Human molecular genetics.

The co-chaperone and reductase ERdj5 facilitates rod opsin biogenesis and quality control

D. Athanasiou, M. Aguilà, D. Bevilacqua, 2014, Human molecular genetics.

Biophysical Properties of 9 KCNQ 1 Mutations Associated with Long QT Syndrome ( LQTS )

A. Shelling, J. Skinner, Ping Yang, 2009 .

Biophysical Properties of 9 KCNQ1 Mutations Associated With Long-QT Syndrome

A. Shelling, J. Skinner, D. Roden, 2009, Circulation. Arrhythmia and electrophysiology.

Site-Directed KCNQ 1 Mutagenesis and Transient Transfection in Chinese Hamster Ovary Cells

A. Shelling, J. Skinner, D. Roden, 2009 .

Long QT and Brugada syndrome gene mutations in New Zealand.

A. Shelling, J. Skinner, M. Rees, 2007, Heart rhythm.

Near-miss SIDS due to Brugada syndrome

J. Skinner, M. Rees, J. French, 2005, Archives of Disease in Childhood.

The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy

D. Athanasiou, M. Aguilà, J. Bellingham, 2017, Progress in Retinal and Eye Research.

The heat-shock response co-inducer arimoclomol protects against retinal degeneration in rhodopsin retinitis pigmentosa

B. Kalmar, L. Greensmith, Peter M. G. Munro, 2014, Cell Death and Disease.

Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study

I. Graham, F. Muntoni, P. Nihoyannopoulos, 2009, The Lancet. Neurology.